What's new

Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine Syndrome), 26/02/2025 Positive

Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine Syndrome), 26/02/2025 Positive

Mar 11, 2025 - 13:35
 0
Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine Syndrome), 26/02/2025 Positive
Orphan designation: Treatment of X-linked hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine Syndrome), 26/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Rimeporide Treatment of Duchenne muscular dystrophy, 26/02/2...

Next Article

Gerry Weber slides into insolvency again

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2025, 10:00 (CET) to 19 November 2025, 12:00 (CET)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Summary of opinion: Simparica Trio, 12/02/2025 Positive

Summary of opinion: Simparica Trio, 12/02/2025 Positive

Feb 14, 2025  0

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025, 09:00 (CEST) to 2 April 2025, 15:50 (CEST)

European Medicines Agency (EMA) Patients' and Consumers...

Mar 3, 2025  0